Related Experiment Video
Updated: Jan 3, 2026
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
The Potential for Chemotherapy-Free Strategies in Advanced Prostate Cancer
1Department of Internal Medicine, Division of Medical Oncology, Recep Tayyip Erdogan University Faculty of Medicine, Rize.
Abstract:
The treatment landscape for advanced prostate cancer is evolving rapidly, with new agents and strategies, and more optimal use of existing therapies under constant development. Efforts were focused on better understanding of the biology of the disease. This effort has paved the way for a more contemporary and effective therapies to be developed. There are now 6 FDA-approved therapies that increase overall survival. These include the immunotherapy sipuleucel-T; the 2 androgen pathway inhibitors: abiraterone acetate and enzalutamide; 2 chemotherapy drugs: docetaxel and cabazitaxel; and the radionuclide: radium-223. Advanced prostate cancer may be one of the few cancers for which multiple chemotherapy and nonchemotherapy regimens are considered as standard. Several recently published clinical trials have demonstrated the suprising activity of chemotherapy-free strategies, and we should not be too eager to discount these "old-fashioned" treatments. Optimal sequencing is still unclear because new therapies have proliferated so quickly that comparative data are limited. In this short communication, we identify current challenges and unmet needs in advanced prostate cancer and provide an overview of their respective clinical activity, while highlighting distinctions between therapies.
Insights
The advanced prostate cancer treatment landscape is rapidly evolving. New and existing therapies, including immunotherapy, androgen inhibitors, chemotherapy, and radium-223, offer improved survival, but optimal sequencing remains a challenge.
Area of Science:
- Oncology
- Medical Therapeutics
Background:
- The treatment of advanced prostate cancer is dynamic, with ongoing development of novel agents and therapeutic strategies.
- A deeper understanding of prostate cancer biology has led to more effective therapies.
Purpose of the Study:
- To identify current challenges and unmet needs in advanced prostate cancer management.
- To provide an overview of the clinical activity of approved therapies for advanced prostate cancer.
- To highlight distinctions between different treatment modalities.
Main Methods:
- Review of current literature and clinical trial data on advanced prostate cancer therapies.
- Analysis of FDA-approved treatments including immunotherapy, androgen pathway inhibitors, chemotherapy, and radionuclide therapy.
- Discussion of emerging treatment strategies and their comparative efficacy.
Main Results:
- Six FDA-approved therapies improve overall survival in advanced prostate cancer: sipuleucel-T, abiraterone acetate, enzalutamide, docetaxel, cabazitaxel, and radium-223.
- Both chemotherapy and non-chemotherapy regimens are considered standard of care.
- Chemotherapy-free strategies show surprising activity, challenging traditional treatment approaches.
Conclusions:
- Optimal sequencing of therapies for advanced prostate cancer is not yet clearly defined due to the rapid proliferation of new treatments and limited comparative data.
- Continued research is needed to address challenges and unmet needs in advanced prostate cancer care.
- A comprehensive understanding of individual therapy profiles is crucial for effective treatment selection.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistant Cancers
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy